Reaction

Malignant Melanoma Stage 0 reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 179 reports · 52 co-occurring drugs

As of the last recalculation, Malignant Melanoma Stage 0 appears in 179 FAERS reports alongside 52 co-occurring drug terms. The strongest observed disproportionality signal is OSELTAMIVIR (PRR 801.1).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Oseltamivir	42	801.1	805.3
Phytonadione	43	775.4	779.4
Dalteparin Sodium	44	640.9	643.6
Amiodarone Hydrochloride	43	587.0	589.3
Dextrose	45	530.4	532.3
Bisacodyl Suppositories	44	523.9	525.7
Dextrose Monohydrate	45	522.7	524.4
Biscodyl	44	519.2	521.0
Norepinephrine Bitartrate	45	485.2	486.8
Bisacodyl	44	481.6	483.2
Instalax Polyethylene Glycol 3350	37	436.8	438.2
Polyethylene Glycol 400	37	427.4	428.6
Calcitriol Capsules 0.25 Mcg	49	391.0	392.0
Calcitriol Capsules 0.5 Mcg	49	391.0	392.0
Calcitriol	49	386.5	387.5
Heparin Sodium	32	329.2	330.0
Acetylcysteine	23	325.5	326.3
Oseltamivir Phosphate	47	303.1	303.7
Ceftriaxone Sodium	61	280.0	280.5
Ciclesonide	24	236.5	236.9
Norepinephrine	18	217.6	218.0
Mesalamine	62	195.9	196.1
Ipratropium Bromide	45	195.6	195.8
Dexlansoprazole	47	177.3	177.5
Melatonin	55	169.1	169.3
Fluticasone Furoate	16	168.6	168.8
Docusate Sodium 100Mg	28	161.2	161.4
Budesonide	55	156.3	156.4
Biotin	32	145.0	145.1
Metronidazole Topical	44	142.0	142.2
Doxyclycline Hyclate	18	136.5	136.7
Magnesium Oxide	38	133.8	133.9
Darbepoetin Alfa	46	133.2	133.3
Theophylline Anhydrous	13	131.4	131.5
Insulin Degludec	23	130.6	130.7
Theophylline	12	130.0	130.2
Salmeterol Xinafoate	9	127.8	127.9
Candesartan	32	126.8	126.9
Polyethylene Glycol	11	125.8	126.0
Naproxen Sodium Tablet, Coated	13	120.3	120.4
Naproxen Sodium, Coated Tablets	13	120.3	120.4
Naproxen Sodium 220Mg	13	120.1	120.2
Tamsulosin Hydrochloride	18	113.9	114.0
Psyllium Husk	9	111.5	111.6
Insulin Aspart	45	105.4	105.5
Calcium Gluconate	10	102.1	102.2
Ceftriaxone	24	98.1	98.1
Mepolizumab	33	94.5	94.5
Fluticasone Furoate, Umeclidinium Bromide And Vilanterol Trifenatate	25	81.4	81.5
Fluticasone Furoate And Vilanterol Trifenatate	21	76.8	76.8
Hydromorphone Hydrochloride	41	66.9	67.0
Encorafenib	3	35.8	35.8

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.